skip to Main Content
Minnesota Medical Marijuana Patients Experiencing Shortages

Several Minnesotans say they are struggling to get their prescribed medicine that they consider life-changing.

LeafLine Labs is one of two medical marijuana companies in the state. Some of its patients have to wait nearly a week to get their prescriptions filled.

Kellie Germin uses medical marijuana to treat her post traumatic stress disorder.

“As hard as it is for me to go without it, you know, I think about the patients who are far worse than me,” Germin said. “It means being functional, active, being able to be part of social groups, sleeping, eating.”

Her prescription is through LeafLine Labs. She said when she calls to get a refill she typically picks it up on the same day.

But when Germin called Tuesday morning, she said she was told it would take six days.

“Anxiety, a lot of anxiety,” she said. “Oh my gosh, what am I going to do? Oh my gosh, what are the other patients going to do?”

Her story echoed several others in a Facebook group for medical marijuana patients in Minnesota, all complaining about prescription delays at LeafLine Labs.

Dr. Andrew Bachman, CEO and chief medical officer for LeafLine Labs, said the state mandates that medicine samples be submitted to a third-party lab for testing. [Read more at CBS Minnesota]

This Post Has 0 Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Recent Stories

Hawaii Senate Kills ‘De Facto’ Weed Legalization

A bill to increase the amount of marijuana a person can possess before facing stiff criminal penalties failed 15-9 in the Hawaii Senate on Monday. It was the second defeat…

Kentucky’s Medical Cannabis Program Undergoes Dramatic Transformation: Navigating HB 829 and the Emergency Licensing Regulations

By Hannah King and Arin Aragona Plans for Kentucky’s medical cannabis program took a significant turn last week with the passage of House Bill 829 and the implementation of emergency…

Cannabis in Court: When Federal Courts Will Hear Commercial Disputes Related to the Cannabis Business

By Steven Ascher and Anna M.Windemuth The unique status of the cannabis business —  legal in a majority of states, but still illegal under federal law — creates a thorny…

Patchwork Regulation of CBD Products Continues Despite Rise in Demand

By Courtney A. Hunter and Jessalyn H. Zeigler Demand for cannabidiol (CBD) products continues to climb, and the market has risen to the occasion. There is now a robust array…

More Categories

Back To Top
×Close search
Search